Lyell Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Sell |
5,774
-10,508
| -65% | -$1.33M | 0.06% | 133 |
|
|
2025
Q1 | $2.08M | Sell |
16,282
-6,590
| -29% | -$843K | 0.19% | 91 |
|
|
2024
Q4 | $3.02M | Buy |
22,872
+598
| +3% | +$79.1K | 0.27% | 86 |
|
|
2024
Q3 | $3.24M | Buy |
22,274
+735
| +3% | +$107K | 0.29% | 85 |
|
|
2024
Q2 | $2.96M | Buy |
21,539
+145
| +0.7% | +$19.9K | 0.28% | 86 |
|
|
2024
Q1 | $2.94M | Buy |
21,394
+829
| +4% | +$114K | 0.3% | 85 |
|
|
2023
Q4 | $2.79M | Sell |
20,565
-1,377
| -6% | -$187K | 0.32% | 84 |
|
|
2023
Q3 | $2.68M | Sell |
21,942
-4,615
| -17% | -$564K | 0.36% | 81 |
|
|
2023
Q2 | $3.37M | Buy |
26,557
+515
| +2% | +$65.4K | 0.43% | 75 |
|
|
2023
Q1 | $3.36M | Buy |
26,042
+2,205
| +9% | +$285K | 0.47% | 72 |
|
|
2022
Q4 | $3.13M | Buy |
+23,837
| New | +$3.13M | 0.49% | 69 |
|
|
2022
Q3 | – | Sell |
-3,920
| Closed | -$461K | – | 195 |
|
|
2022
Q2 | $461K | Buy |
3,920
+1,782
| +83% | +$210K | 0.08% | 134 |
|
|
2022
Q1 | $279K | Buy |
+2,138
| New | +$279K | 0.04% | 175 |
|
|
2021
Q4 | – | Sell |
-2,006
| Closed | -$324K | – | 189 |
|
|
2021
Q3 | $324K | Buy |
+2,006
| New | +$324K | 0.04% | 154 |
|